ESCRS - Mayo Clinic researchers demonstrate value of second opinions ;
ESCRS - Mayo Clinic researchers demonstrate value of second opinions ;

Mayo Clinic researchers demonstrate value of second opinions

88 percent of patients go home with a new or refined diagnosis

Mayo Clinic researchers demonstrate value of second opinions
Colin Kerr
Colin Kerr
Published: Tuesday, April 4, 2017
Second Opinion?
In a new study, the Mayo Clinic has reported that many patients come to their clinic for a second opinion or diagnosis confirmation before treatment for a complex condition. As many as 88 percent of those patients go home with a new or refined diagnosis. Conversely, only 12 percent receive confirmation that the original diagnosis was complete and correct. These findings were published online in the Journal of Evaluation in Clinical Practice. The research team was led by James Naessens, Sc.D., a health care policy researcher at Mayo Clinic.
Tags: patients
Latest Articles
From Lab to Life: Corneal Repair Goes Cellular

Long-awaited cellular therapies for corneal endothelial disease enter the clinic.

Read more...

Balancing Innovation and Safety

Ensuring access to advanced cell therapies amid regulatory overhaul.

Read more...

With Eyes on Its Future, ESCRS Celebrates Its Past

Winter Meeting offers opportunities to experiment with new concepts and formats.

Read more...

Best of ESCRS Winter Meeting 2024

Read more...

Following the New Generation

EDOF IOLs an option for eyes with mild comorbidities, showing potential in mini-monovision strategies.

Read more...

Refocus on Multifocals

Trifocal IOLs continue to improve as consensus grows regarding indications and contraindications.

Read more...

Common Myths in Presbyopia Correction

Patient education key to satisfaction with refractive IOLs.

Read more...

Reversible Multifocality

Two-lens combination offers low-risk spectacle independence for cataract patients and presbyopes.

Read more...

Managing a Cataract Surgery Refractive Miss

Weighing the pros and cons of options for intraocular intervention.

Read more...

Unleashing OCT’s Full Potential

Performance of newest tool for corneal evaluation meets or beats older standard technologies.

Read more...

;